ArticleAntimicrobial agents and chemotherapy2024
Erratum issuedOpen access · greenAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 16 citations in OpenAlex.
- Approaching the post-antibiotic era: phage therapy current practices and future horizons.mBio · 2026Review
- First UK use of bacteriophage therapy with DAIR for chronicASM case reports · 2026Article
- Phage as a prospective arsenal against superbugs.Molecular biology reports · 2026Review
- CApEsid biOfilm: a suggested pipeline for clinical phage microbiology for biofilm infections based on comparative method study.Scientific reports · 2026Article
- From hype to hope: reanimating phage therapy through evidence-based multidisciplinarity.Nature communications · 2026Review
- Clearance of hypermutator XDRASM case reports · 2026Article
- Genomic and functional characterization ofFrontiers in microbiology · 2026Article
- Harnessing phages in the age of antibiotic resistance: immunological perspectives.Frontiers in immunology · 2026Review
- Article
- Phage to ESKAPE: Personalizing Therapy for MDR Infections-A Comprehensive Clinical Review.Pathogens (Basel, Switzerland) · 2025Review
- Biocontrol of Phage Resistance inViruses · 2025Review
- [Medical ethical challenges of phage therapy-informed consent, study design and therapeutic trial].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025Article
- Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States.Antibiotics (Basel, Switzerland) · 2025Review
- Large-Scale Genomic Analysis of CpG-Mediated Immunogenicity in Bacteriophages and a Novel Predictive Risk Index.bioRxiv : the preprint server for biology · 2025Article
- Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.The Journal of clinical investigation · 2025Review
- Emerging antimicrobial therapies for Gram-negative infections in human clinical use.npj antimicrobials and resistance · 2025Review
- Bacteriophages: A Challenge for Antimicrobial Therapy.Microorganisms · 2025Review
- Translational research priorities for bacteriophage therapeutics.Essays in biochemistry · 2024Review
- Current status of bacteriophage therapy for severe bacterial infections.Journal of intensive care · 2024Review
- Phage Therapy for Cardiac Implantable Electronic Devices and Vascular Grafts: A Targeted Literature Review.Pathogens (Basel, Switzerland) · 2024Review
Corrections and comments
- Erratum issued
Authors and funding
29 authors at 9 institutions in 2 countries.
Saima AslamDivision of Infectious Diseases and Global Public Health and the Center for Innovative Phage Applications and Therapeutics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-4051-5629
Dwayne RoachDepartment of Biology, San Diego State University, San Diego, California, USA.ORCID 0000-0002-2069-8915
Mikeljon P NikolichBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Biswajit BiswasNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.
Robert T SchooleyDivision of Infectious Diseases and Global Public Health and the Center for Innovative Phage Applications and Therapeutics, University of California San Diego, La Jolla, California, USA.
Kimberley A Lilly-BishopNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.ORCID 0000-0002-5744-8493
Gregory K RiceNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.
Regina Z CerNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.
Theron HamiltonNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.
Matthew HenryNaval Medical Research Command - Frederick, Fort Detrick, Maryland, USA.
Tiffany LuongDepartment of Biology, San Diego State University, San Diego, California, USA.
Ann-Charlott SalabarriaDepartment of Biology, San Diego State University, San Diego, California, USA.
Laura Sisk-HackworthDepartment of Biology, San Diego State University, San Diego, California, USA.
Andrey A FilippovBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.ORCID 0000-0003-2256-861X
Francois LebretonBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.ORCID 0000-0002-7157-5026
Lindsey HallBacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Ran Nir-PazDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Hadil OnallahDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Gilat LivniSchneider Children's Medical Center, Petah Tikva, Israel.
Eran ShostakSchneider Children's Medical Center, Petah Tikva, Israel.
Anat Wieder-FinesodThe Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Dafna YahavThe Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Ortal YerushalmyInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Sivan Alkalay-OrenInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Ron BraunsteinInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Leron KhalifaInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Amit RimonInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Daniel GelmanInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Ronen HazanInstitute of Biomedical and Oral Research (IBOR), Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0001-9967-730X
Hebrew University of Jerusalem · ILNaval Medical Research Command · USSan Diego State University · USWalter Reed Army Institute of Research · USHadassah Medical Center · ILSchneider Children's Medical Center · ILSheba Medical Center · ILUniversity of California San Diego · USLeidos (United States) · US
Funding
DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP) PR182667DOD | USN | BUMED | Naval Medical Research Command (NMRC) A1417Israeli Science Foundation IPMP ISF_1349 /20Milgrom Family Support ProgramRosetrees Trust (Rosetrees) A2232United States Israel Binational Science Foundation 2017123University of California Chancellor's Innovation Fund
Abstract
Left ventricular assist devices (LVAD) are increasingly used for management of heart failure; infection remains a frequent complication. Phage therapy has been successful in a variety of antibiotic refractory infections and is of interest in treating LVAD infections. We performed a retrospective review of four patients that underwent five separate courses of intravenous (IV) phage therapy with concomitant antibiotic for treatment of endovascular
Indexed as
BacteremiaBacteriophagesHeart-Assist DevicesPhage TherapyPseudomonas InfectionsAnti-Bacterial AgentsHumansProphagesPseudomonas aeruginosaAnti-Bacterial Agentsdevice-related infectionLVADMDROphage therapyPseudomonas aeruginosa
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.